HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $541,000 | -61.6% | 203,464 | 0.0% | 0.09% | -55.9% |
| Q1 2017 | $1,408,000 | +208.8% | 203,464 | 0.0% | 0.20% | +234.4% |
| Q4 2016 | $456,000 | -3.4% | 203,464 | 0.0% | 0.06% | +17.3% |
| Q3 2016 | $472,000 | -10.8% | 203,464 | 0.0% | 0.05% | -30.7% |
| Q2 2016 | $529,000 | -8.3% | 203,464 | +1.2% | 0.08% | -13.8% |
| Q1 2016 | $577,000 | -34.1% | 201,000 | 0.0% | 0.09% | -17.1% |
| Q4 2015 | $876,000 | -42.8% | 201,000 | 0.0% | 0.10% | -57.1% |
| Q3 2015 | $1,532,000 | -31.6% | 201,000 | 0.0% | 0.24% | -17.8% |
| Q2 2015 | $2,241,000 | – | 201,000 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PERKINS CAPITAL MANAGEMENT INC | 2,426,300 | $802,000 | 0.74% |
| Cowen Prime Services LLC | 1,411,500 | $466,000 | 0.23% |
| GSA CAPITAL PARTNERS LLP | 1,205,873 | $398,000 | 0.07% |
| Nantahala Capital Management | 5,113,958 | $1,690,000 | 0.05% |
| HighMark Wealth Management LLC | 80,000 | $26,000 | 0.02% |
| Kalos Management, Inc. | 72,858 | $24,000 | 0.01% |
| Qube Research & Technologies Ltd | 585,187 | $193,000 | 0.00% |
| WINTON GROUP Ltd | 190,146 | $63,000 | 0.00% |
| Ironwood Financial, llc | 1,571 | $1,000 | 0.00% |
| Virtu Financial LLC | 12,049 | $4,000 | 0.00% |